Lamivudine Oral Solution

DRUG3 trials

Sponsors

ANRS, Emerging Infectious Diseases, University of Alabama at Birmingham

Conditions

HIV-1Hepatitis B Infection

Phase 2

Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV

ANRS, Emerging Infectious DiseasesHIV-1

Start: 2019-12-04End: 2022-03-31Updated: 2022-03-31

Phase 3

Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention

CompletedNCT03870438

ANRS, Emerging Infectious DiseasesHIV-1

Start: 2019-12-14End: 2022-10-31Updated: 2022-12-07

Reducing Vertical Transmission of Hepatitis B in Africa

Active, not recruitingNCT04704024

University of Alabama at BirminghamHepatitis B Infection

Start: 2021-09-03End: 2026-12-31Updated: 2026-08-24

Related Papers

An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV).

2024-09-201 citations

Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.

2024-03-116 citations

PA-372 Evaluation of the prevention of mother-to-child transmission of HIV programs at the second immunization visit in Burkina Faso and Zambia, countries with different HIV epidemics

2023-12-01

Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso.

2021-04-177 citations